| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
2018 12-31 |
|---|---|---|---|---|---|---|---|---|
| Report Filing | 2025-03-07 | 2024-03-13 | 2023-03-21 | 2022-03-01 | 2021-06-21 | 2019-12-31 | 2018-12-31 | |
| Revenue | 2,423 | 2,290 | 1,851 | 763 | 793 | 2,119 | 1,899 | |
| Cost of Revenue | 967 | 958 | 832 | 477 | 529 | 880 | 813 | |
| Gross Profit | 1,456 | 1,332 | 1,019 | 286 | 264 | 1,239 | 1,086 | |
| Operating Expenses | 1,341 | 1,340 | 1,220 | 832 | 1,011 | 1,033 | 988 | |
| Research & Development | 442 | 405 | 388 | 264 | 277 | 339 | 0.00 | |
| Selling, General and Administrative | 708 | 699 | 650 | 414 | 380 | 541 | 863 | |
| Other Operating Expenses | 191 | 236 | 182 | 154 | 354 | 153 | 125 | |
| Operating Income | 115 | -8.00 | -201 | -546 | -747 | 206 | 98.0 | |
| Net Non-Operating Interest | -109 | -140 | 0.00 | -52.0 | -26.0 | -10.0 | 3.00 | |
| Interest Income | 6.00 | 1.00 | 98.0 | 1.00 | 1.00 | 5.00 | 3.00 | |
| Interest Expense | 115 | 141 | 98.0 | 53.0 | 27.0 | 15.0 | 0.00 | |
| Equity & Other Income/(Expense) | -77.0 | 3.00 | -86.0 | -55.0 | 14.0 | -3.00 | -61.0 | |
| Income Before Tax | -71.0 | -145 | -287 | -653 | -759 | 193 | 40.0 | |
| Income Tax Expense | 66.0 | -9.00 | -61.0 | -186 | -145 | 60.0 | 18.0 | |
| Income Attributable to Non-Controlling Interest | 1.00 | -73.0 | 0.00 | 0.00 | 0.00 | -1.00 | 3.00 | |
| Net Income | -138 | -63.0 | -226 | -467 | -614 | 134 | 19.0 | |
| Depreciation and Amortization | 178 | 194 | 182 | 154 | 148 | 141 | 84.0 | |
| EBITDA | 293 | 186 | -19.0 | -392 | -599 | 347 | 182 | |
| Earnings Per Share (EPS) | -0.300 | -0.140 | -4.410 | -6.890 | -6.010 | 1.040 | 0.150 | |
| Diluted Earnings Per Share | -0.300 | -0.140 | -0.510 | -6.890 | -6.010 | 1.040 | 0.150 | |
| Weighted Average Shares Outstanding | 463 | 464 | 51.3 | 67.8 | 102 | 129 | 129 | |
| Diluted Weighted Average Shares Outstanding | 463 | 458 | 446 | 67.8 | 102 | 129 | 129 |
